Virgilio Deloy Capobian Gibbon Sells 3,900 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 3,900 shares of the stock in a transaction on Wednesday, March 25th. The shares were sold at an average price of $15.18, for a total value of $59,202.00. Following the sale, the chief executive officer directly owned 154,548 shares in the company, valued at $2,346,038.64. This trade represents a 2.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The stock was sold at an average price of $15.21, for a total value of $12,168.00.

Afya Stock Performance

Shares of AFYA stock opened at $14.75 on Friday. The company has a quick ratio of 0.98, a current ratio of 2.20 and a debt-to-equity ratio of 0.21. The company has a 50 day moving average price of $14.39 and a 200-day moving average price of $14.74. Afya Limited has a 52 week low of $13.00 and a 52 week high of $19.90. The firm has a market capitalization of $1.38 billion, a PE ratio of 10.10, a P/E/G ratio of 0.67 and a beta of 0.52.

Afya (NASDAQ:AFYA) last issued its quarterly earnings data on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The company had revenue of $147.08 million for the quarter, compared to the consensus estimate of $174.74 million. As a group, equities research analysts expect that Afya Limited will post 1.52 earnings per share for the current year.

Afya Announces Dividend

The company also recently declared an annual dividend, which will be paid on Monday, April 6th. Stockholders of record on Wednesday, March 25th will be paid a $0.656 dividend. This represents a dividend yield of 433.0%. The ex-dividend date is Wednesday, March 25th. Afya’s dividend payout ratio (DPR) is 45.21%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Bank of America cut Afya from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research report on Friday, January 16th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $22.00 price objective (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. Finally, Zacks Research raised shares of Afya from a “strong sell” rating to a “hold” rating in a report on Monday, March 9th. One analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, Afya currently has a consensus rating of “Hold” and a consensus price target of $17.30.

Institutional Trading of Afya

Several institutional investors have recently made changes to their positions in AFYA. XTX Topco Ltd bought a new stake in Afya during the 4th quarter valued at approximately $215,000. Mangrove Partners IM LLC bought a new position in Afya in the 4th quarter worth approximately $197,000. State Street Corp grew its holdings in Afya by 25.8% during the 4th quarter. State Street Corp now owns 126,914 shares of the company’s stock valued at $1,955,000 after buying an additional 26,005 shares in the last quarter. Campbell & CO Investment Adviser LLC grew its holdings in Afya by 45.3% during the 4th quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company’s stock valued at $612,000 after buying an additional 12,365 shares in the last quarter. Finally, Banco BTG Pactual S.A. bought a new stake in shares of Afya during the fourth quarter valued at approximately $462,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.